Literature DB >> 8132871

Age-related increase in the total number of corticotropin-releasing hormone neurons in the human paraventricular nucleus in controls and Alzheimer's disease: comparison of the disector with an unfolding method.

F C Raadsheer1, D E Oorschot, R W Verwer, F J Tilders, D F Swaab.   

Abstract

It has been hypothesized that the corticotropin-releasing hormone (CRH) neurons of the hypothalamic paraventricular nucleus (PVN) become hyperactive with age, and even more so in Alzheimer's disease. This hyperactivity could be due to an increased production of CRH per neuron, or an increased number of PVN neurons producing CRH, or both. As a first step in elucidating which of these biological mechanisms might be operative, we have estimated the absolute number of CRH immunoreactive neurons in the PVN of 10 human control subjects between 36 and 91 years of age and 10 Alzheimer patients between 40 and 97 years of age. CRH neurons were immunocytochemically detected in 6 microns paraffin sections with the aid of a highly specific monoclonal antibody to CRH. The antibody signal was amplified by the biotin-streptavidin and alkaline phosphatase methods. The absolute number of CRH neurons in the PVN was obtained by multiplying the number of CRH neurons in a unit volume (NV) by the total volume of the PVN. Two different methods were used to estimate the NV: an unfolding method and a disector method (about three times more time-consuming). Compared to the disector, the unfolding method consistently yielded a lower cell number for all patients by 38% (+/- 2.8%; mean +/- SEM). However, both methods yielded an increase in the absolute number of CRH neurons in control and Alzheimer patients with age. No statistically significant difference in the absolute number of CRH neurons was found between control and Alzheimer patients with both methods. The age-dependent increase in the absolute number of CRH neurons within the PVN of both control and Alzheimer patients is interpreted as a sign of activation of the CRH neurons with age.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8132871     DOI: 10.1002/cne.903390311

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  8 in total

1.  Neuron numbers in the hypothalamus of the normal aging rhesus monkey: stability across the adult lifespan and between the sexes.

Authors:  D E Roberts; R J Killiany; D L Rosene
Journal:  J Comp Neurol       Date:  2012-04-15       Impact factor: 3.215

Review 2.  Disruption of fetal hormonal programming (prenatal stress) implicates shared risk for sex differences in depression and cardiovascular disease.

Authors:  J M Goldstein; R J Handa; S A Tobet
Journal:  Front Neuroendocrinol       Date:  2013-12-16       Impact factor: 8.606

3.  Expression patterns of corticotropin-releasing factor, arginine vasopressin, histidine decarboxylase, melanin-concentrating hormone, and orexin genes in the human hypothalamus.

Authors:  David M Krolewski; Adriana Medina; Ilan A Kerman; Rene Bernard; Sharon Burke; Robert C Thompson; William E Bunney; Alan F Schatzberg; Richard M Myers; Huda Akil; Edward G Jones; Stanley J Watson
Journal:  J Comp Neurol       Date:  2010-11-15       Impact factor: 3.215

4.  Hormonal influences on brain ageing quality: focus on corticotropin releasing hormone-, vasopressin- and oxytocin-immunoreactive neurones in the human brain.

Authors:  L Calzà; M Pozza; F Coraddu; G Farci; L Giardino
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

Review 5.  Development of the human hypothalamus.

Authors:  D F Swaab
Journal:  Neurochem Res       Date:  1995-05       Impact factor: 3.996

Review 6.  Stress induced neural reorganization: A conceptual framework linking depression and Alzheimer's disease.

Authors:  Jennifer A Ross; Gediminas Gliebus; Elisabeth J Van Bockstaele
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-08-10       Impact factor: 5.201

7.  In Obesity, HPA Axis Activity Does Not Increase with BMI, but Declines with Aging: A Meta-Analysis of Clinical Studies.

Authors:  Judit Tenk; Péter Mátrai; Péter Hegyi; Ildikó Rostás; András Garami; Imre Szabó; Margit Solymár; Erika Pétervári; József Czimmer; Katalin Márta; Alexandra Mikó; Nóra Füredi; Andrea Párniczky; Csaba Zsiborás; Márta Balaskó
Journal:  PLoS One       Date:  2016-11-21       Impact factor: 3.240

Review 8.  Corticotropin releasing factor-binding protein (CRF-BP) as a potential new therapeutic target in Alzheimer's disease and stress disorders.

Authors:  Dorien Vandael; Natalia V Gounko
Journal:  Transl Psychiatry       Date:  2019-10-22       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.